Replies to post #509835 on Anavex Life Sciences Corp (AVXL)

[sab63090]

Tom:

Have a nice Thanksgiving!

I pretty much stick with what I see until I'm proven wrong and don't try to catch these smaller moves....we've had our butts kicked but I guess there's hope!

I will back away for the next while and consider how the stock behaves and what we will learn from the Anavex group about negotiations....I think I'm more comfortable with my eventual exit if need be.

Good luck to you and all here!

Steve

[Kentucky123]

Agree it will be tricky. I am taking the liberty of using Chucks' chart indicators. The ADX line has hooked over indicating a change in trend MACD turned up as well as RSi. Price is above 4 ema and Candlestick pattern up.

https://schrts.co/KcKJdINi

Short term looks up. JMHO

[oldmystic]

Guessing what kind of gyrations up and down the price action does in these next few weeks will be very tricky in my view.

Tom TA University

[ExtremelyBullishZig]

The only thing I see wrong with that picture is the $10ncap on approval. When am AD drug is approved. It will generally catapult to what AD drugs are worth. If it is an approval without conditions, since it is Europe and not the U.S. I would expect $100. If it were the U.S. it would add $15B to $20B to the market cap before coming down a little to settle. If it is conditional, it means as long as it proofs to be safe and just as effective as the EMA considers it, it will be eventually approved fully, so I would give it a $50 to $70 price.
I am leaning between $1.25 to $2.25 price after the December decision and meaningless CTAD pump.